Skip to content
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Contact Us

A5AD40B5-EEC5-448C-A4F0-FD84C6A228CF (1)

A5AD40B5-EEC5-448C-A4F0-FD84C6A228CF (1)

seraspec May 16, 2019

← Seraph Closes $4.2 Million Series B

Recent Posts

  • Seraph Enhances Board of Directors
  • Seraph Welcomes Dr. Hür Köser!
  • Dr. Creager Joins Seraph’s Board of Directors
  • Dr. Ishaque Joins Seraph’s Board of Directors
  • Nature Biotechnology: Radical Solutions
  • From Theory to Practice: A Profile on Seraph’s Advanced Quality Engineer
  • Seraph Scientist publishes research on novel diagnostic methods
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Terms and Conditions
  • Media Inquiries
  • Contact Us
1001 Woodward Ave. Suite 500 | Detroit, MI 48226 | Seraph Biosciences, Inc.
Top